z-logo
open-access-imgOpen Access
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design
Author(s) -
Howard Trachtman,
Suzanne Vento,
Debbie S. Gipson,
Larysa Wickman,
Jennifer Gassman,
Melanie S. Joy,
Virginia J. Savin,
Michael J.G. Somers,
Maury Pinsk,
Tom Greene
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/fpt2-0a66
Subject(s) - focal segmental glomerulosclerosis , font , clinical trial , medicine , computer science , artificial intelligence , glomerulonephritis , kidney

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom